September 26, 2017

Mountain View, California

Digital Health

Transforming Drug Development

 

Translational Science Forum

Co-​organized by:

 

 

Digital Health Challenge

 

Have a passion for creating novel digital solutions to solve drug development’s most difficult problems?

Present at the MedImmune California Translational Science Forum on September 26, 2017.

Five finalists will have a chance to win the grand prize by presenting to a panel of prominent industry funding experts and executives:

     

  • Julia Belaya, Director of Corporate Partnerships, Healthcare Innovation, Plug and Play

  • Yan Cao, Program Director, Diagnostics & Digital Health Catalyst, UCSF Innovation Ventures

  • Alice Jacobs, Advisor, Third Rock Ventures

  • Jane Osbourn, Vice President, R&D, MedImmune

  • John Trainer, Vice President, Strategic Partnering & Business Development, MedImmune

  • Samuel Wu, Managing Partner, Acuris Partners

  • Please click here for more information on our judges.

  •  

 

Applications are no longer accepted. Finalists will be announced Friday, September 15th.

 

 

Choose from a list of 5 topics and

submit your best solution!

 

 

 

 

 

 

 

 

 

 

 

 

 

SELECTION CRITERIA

Product

Technical Feasibility

Marketing/Strategy

Leadership Team

Financial/Projection

 

 

PRIZES

Grand Prize winner will receive $20,000 and mentoring opportunities from MedImmune

 

All finalists will receive mentoring opportunities from MedImmune

 

Deadline for entries is 9/8/17– Finalists will be announced by 9/15/17

 

 

Mhealth solution for early detection of asthma symptoms and disease monitoring

 

Data mining to maximize patient recruitment (e.g. patient inclusion and exclusion criteria)

 

Digital solution to improve site and patient trial experience, e.g. communication, just-​in-​time reminders, trial progress reporting, virtual visits

 

Integrated analytical platform for collecting and analyzing physiological parameters, symptoms and digital biomarkers (e.g. glucose, weight, activity, sleep etc.)

 

Digital solutions to simplify and accelerate end to end clinical trial execution, including overall trial management, real time data access and review and drug adverse event data reporting

 

© MedImmune 2017